Table 3.
Compound | Experimental Model | Cell or Animal | Method for Detecting Proliferation | Outcomes Offered by Extract | Reference |
---|---|---|---|---|---|
Resveratrol | In vitro | Primary culture of human keratinocytes | MTT assay and hemocytometer cell counting | Dose-dependent antiproliferative activity | Holian and Walter [100] |
Resveratrol | In vitro | Primary culture of human keratinocytes | 7-aminoactinomycin D assay | Reduced aquaporin 3 expression | Wu et al. [101] |
Curcumin | In vitro | TNF-α-activated HaCaT | Annexin-V staining | Apoptosis is the main mechanism for antiproliferation of HaCaT | Sun et al. [104] |
Curcumin | In vitro | HaCaT | Nuclei staining | Increased apoptosis by the combination with UVA or visible light | Dujic et al. [105] |
Curcumin | In vitro | TNF-α-activated HaCaT | Cell counting kit-8 and LDH assay | Increased apoptosis by the combination with red and blue light | Niu et al. [106] |
Rottlerin | In vitro | Primary culture of human keratinocytes | MTT assay | Increased apoptosis in an autophagy-dependent pathway | Min et al. [110] |
Acridone analogs | In vitro | HaCaT | Cell counting and LDH assay | The compounds with benzyl substitution at the 10-position showed potent proliferation inhibition | Putic et al. [112] |
1,4-Dihydroxy-2-naphthoic acid | In vitro | HaCaT | Sulphorhodamine B staining | Dose-dependent antiproliferative activity | Mok et al. [113] |
Arsenics | In vitro | HaCaT | MTT assay | Significant inhibition on keratinocyte growth with moderate toxicity on fibroblasts | Tse et al. [115] |
Arsenic trioxide | In vitro | HaCaT | MTT and LDH assay | Increased apoptosis via ROS-dependent p53 ubiquitination | Shen et al. [116] |
Baicalein | In vitro | HaCaT | Cell counting | Minor inhibition of proliferation without affecting ROS production | Huang et al. [119] |
Celastrol | In vitro | HaCaT and primary human keratinocytes | MTT assay | Increased apoptosis via Bcl-2 attenuation and Bax upregulation | Zhou et al. [120] |
Tanshinone IIA | In vitro | Primary mouse keratinocytes | MTT assay | Increased apoptosis via caspase pathway | Li et al. [122] |
Dehydrocostuslactone and costunolide | In vitro | Primary human keratinocytes | Annexin-V staining | Inhibited proliferation and inflammation-related genes | Scarponi et al. [125] |
Delphinidin | In vitro | 3D reconstructed psoriatic skin equivalent | Ki-67 and PCNA | Inhibited proliferation and inflammation | Chamcheu et al. [126] |
Rhodomyrtone | In vitro/in vivo | HaCaT/rabbit | MTT assay | Elevated apoptosis with no skin irritation | Chorachoo et al. [129] |
Rhodomyrtone | In vitro/in vivo | Human skin organ culture/ICR mouse | Histology | Reduced epidermal thickness and hyperplasia | Chorachoo et al. [130] |
Phytosphingosine derivatives | In vitro/in vivo | HaCaT/hairless mouse | Cell viability assay kit | Increased programmed keratinocyte death | Kim et al. [132] |
Amentoflavone | In vitro/in vivo | HaCaT/Balb/c mouse | Cell counting kit | Inhibited proliferation and epidermal thickness | An et al. [134] |
Periplogenin | In vitro/in vivo | HaCaT/Balb/c mouse | MTT assay | Inhibited proliferation via necroptotic cell death | Zhang et al. [135] |
3β,6β,16β-Trihydroxylup-20(29)-ene | In vitro/in vivo | HaCaT/Swiss mouse | MTT and neutral red assay | Reduced keratinocyte viability via apoptosis and ROS generation | Horinouchi et al. [136] |
Rhododendrin | In vitro/in vivo | Normal human keratinocytes/C57BL/6 mouse | MTT assay | Inhibited proliferation and epidermal thickness | Jeon et al. [139] |
8-Methoxypsoralen derivatives | In vitro/in vivo | HaCaT/Balb/c mouse | MTT assay | Inhibited proliferation and epidermal thickness | Alalaiwe et al. [142] |
Epigallocatechin-3-gallate | In vivo | Balb/c mouse | PCNA | Inhibited epidermal thickness and differentiation regulation | Zhang et al. [144] |
Bax, Bcl-2-associated X protein; LDH, lactate dehydrogenase; MTT, 3-(4,5-cimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; PCNA, proliferating cell nuclear antigen; ROS, reactive oxygen species.